Endogenous nitric oxide synthesis: Biological functions and pathophysiology

Free Radical Research

Volumn 31, Issue 6, 1999, Pages 577-596

  Bredt, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM ION; CITRULLINE; CYTOKINE; DYSTROPHIN; FREE RADICAL; GLUTAMATE RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ALLOSTERISM; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUNTINGTON CHOREA; HYPERTROPHIC PYLORUS STENOSIS; IMPOTENCE; MIGRAINE; MOLECULAR BIOLOGY; MUSCULAR DYSTROPHY; NEUROMODULATION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN PROCESSING; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; STOICHIOMETRY; STROKE;

EID: 0032740245     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769900301161     Document Type: Conference Paper

References (160)

1. L.C. Green, S.R. Tannenbaum and P. Goldman: Nitrate synthesis in the germfree and conventional rat. Science 212: 56, 1981.
2. L.C. Green, K. Ruiz, de Luzuriaga, D.A. Wagner, W. Rand, N. Istfan, V.R. Young and S.R. Tannenbaum: Nitrate biosynthesis in man. Proceedings of the National Academy of Sciences of the United States of America 78: 7764, 1981.
3. D.A. Wagner, V.R. Young, S.R. Tannenbaum, D.S. Schultz and W.M. Deen: Mammalian nitrate biochemistry: metabolism and endogenous synthesis, Iarc Scientific Publications 34: 247, 1984.
4. E. Hegesh and J. Shiloah: Blood nitrates and infantile methemoglobinemia. Clinica Chimica Acta 125: 107, 1982.
5. 3 into nitrate is enhanced by endotoxin treatment. Proceedings of the National Academy of Sciences of the United States of America 80: 4518, 1983.
6. D.J. Stuehr and M.A. Marletta: Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 82: 7738, 1985.
7. D.J. Stuehr and M.A. Marletta: Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Research 47: 5590, 1987.
8. D.J. Stuehr and M.A. Marletta: Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. Journal of Immunology 139: 518, 1987.
9. M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf and J.S. Wishnok: Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27: 8706, 1988.
10. J.B. Hibbs, Jr., Z. Vavrin and R.R. Taintor: L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells, Journal of Immunology 138: 550, 1987.
11. J.B. Hibbs, Jr., R.R. Taintor and Z. Vavrin: Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473, 1987.
12. R.F. Furchgott and J.V. Zawadzki: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373, 1980.
13. T.M. Griffith, D.H. Edwards, M.J. Lewis, A.C. Newby and A.H. Henderson: The nature of endothelium-derived vascular relaxant factor. Nature 308: 645, 1984.
14. T.M. Cocks, J.A. Angus, J.H. Campbell and G.R. Campbell: Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. Journal of Cellular Physiology 123: 310, 1985.
15. R.M. Rapoport and F. Murad: Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circulation Research 52: 352, 1983.
16. W.P. Arnold, C.K. Mittal, S. Katsuki and F. Murad: Nitric oxide activates guanylate cyclase and increases guanosine 3′ :5′-cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America 74: 3203, 1977.
17. L.J. Ignarro, H. Lippton, J.C. Edwards, W.H. Baricos, A.L. Hyman, P.J. Kadowitz and C.A. Gruetter: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics 218: 739, 1981.
18. P.A. Craven and F.R. DeRubertis: Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. Journal of Biological Chemistry 253: 8433, 1978.
19. L.J. Ignarro, J.N. Degnan, W.H. Baricos, P.J. Kadowitz and M.S. Wolin: Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochimica et Biophysica Acta 718: 49, 1982.
20. R.F. Furchgott (1988) Vasodilation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium (Vanhoutte, P.M., Ed), pp. 401, Raven Press, New York.
21. L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns and G. Chaudhuri: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 84: 9265, 1987.
22. L.J. Ignarro, R.E. Byrns and K.S. Wood (1988) Vasodilation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium (Vanhoutte, P.M., Ed), pp. 427, Raven Press, New York.
23. R.M. Palmer, A.G. Ferrige and S. Moncada: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524, 1987.
24. R.M. Palmer, D.S. Ashton and S. Moncada: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664, 1988.
25. R.M. Palmer and S. Moncada: A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochemical and Biophysical Research Communications 158: 348, 1989.
26. H. Azuma, M. Ishikawa and S. Sekizaki: Endothelium-dependent inhibition of platelet aggregation. British Journal of Pharmacology 88: 411, 1986.
27. B. Furlong, A.H. Henderson, M.J. Lewis and J.A. Smith: Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. British Journal of Pharmacology 90: 687, 1987.
28. M.W. Radomski, R.M. Palmer and S. Moncada: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057, 1987.
29. M.W. Radomski, R.M. Palmer and S. Moncada: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 92: 639, 1987.
30. K. Aisaka, S.S. Gross, O.W. Griffith and R. Levi: NG-methylarginine, an inhibitor of endotheliuin-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochemical and Biophysical Research Communications 160: 881, 1989.
31. B.J. Whittle, J. Lopez-Belmonte and D.D. Rees: Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. British Journal of Pharmacology 98: 646, 1989.
32. D.D. Rees, R.M. Palmer and S. Moncada: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proceedings of the National Academy of Sciences of the United States of America 86: 3375, 1989.
33. P. Vallance, J. Collier and S. Moncada: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997, 1989.
34. P. Vallance, J. Collier and S. Moncada: Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovascular Research 23: 1053, 1989.
35. T. Deguchi: Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. Journal of Biological Chemistry 252: 7617, 1977.
36. T. Deguchi and M. Yoshioka: L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. Journal of Biological Chemistry 257: 10 147, 1982.
37. R.G. Knowles, M. Palacios, R.M. Palmer and S. Moncada: Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 86: 5159, 1989.
38. J. Garthwaite, S.L. Charles and R. Chess-Williams: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385, 1988.
39. J.A. Ferrendelli, M.M. Chang and D.A. Kinscherf: Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. Journal of Neurochemistry 22: 535, 1974.
40. J. Garthwaite and R. Balazs: Excitatory amino acid-induced changes in cyclic GMP levels in slices and cell suspensions from the cerebellum. Advances in Biochemical Psychopharmacology 27: 317, 1981.
41. D.S. Bredt and S.H. Snyder: Nitric oxide media glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America 86: 9030, 1989.
42. J. Garthwaite, G. Garthwaite, R.M. Palmer and S. Moncada: NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology 172: 413, 1989.
43. D.S. Bredt and S.H. Snyder: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America 87: 682, 1990.
44. B. Mayer, M. John and E. Böhme: Purification of a Ca2+ /calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Letters 277: 215, 1990.
45. H.H.H.W. Schmidt, J.S. Pollock, M. Nakane, L.D. Gorsky, U. Forstermann and F. Murad: Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proceedings of the National Academy of Sciences of the United States of America 88: 365, 1991.
46. J.M. Hevel, K.A. White and M.A. Marletta: Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. Journal of Biological Chemistry 226: 22 789, 1991.
47. Y. Yui, R. Hattori, K. Kosuga, H. Eizawa, K. Hiki and C. Kawai: Purification of nitric oxide synthase from rat macrophages. Journal of Biological Chemistry 266: 12 544, 1991.
48. D.J. Stuehr, H.J. Cho, N.S. Kwon, M.F. Weise and C.F. Nathan: Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proceedings of the National Academy of Sciences of the United States of America 88: 7773, 1991.
49. T. Evans, A. Carpenter and J. Cohen: Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver. Proceedings of the National Academy of Sciences of the United States of America 89: 5361, 1992.
50. J.S. Pollock, U. Forstermann, J.A. Mitchell, T.D. Warner, H.H. Schmidt, M. Nakane and F. Murad: Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 88: 10 480, 1991.
51. D.S. Bredt, P.M. Hwang, C.E. Glatt, C. Lowenstein, R.R. Reed and S.H. Snyder: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714, 1991.
52. M. Nakane, H.H. Schmidt, J.S. Pollock, U. Forstermann and F. Murad: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Letters 316: 175, 1993.
53. W.C. Sessa, J.K. Harrison, C.M. Barber, D. Zeng, M.E. Durieux, D.D. D'Angelo, K.R. Lynch and M.J. Peach: Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. Journal of Biological Chemistry 267: 15 274, 1992.
54. S. Lamas, P.A. Marsden, G.K. Li, P. Tempst and T. Michel: Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proceedings of the National Academy of Sciences of the United States of America 89: 6348, 1992.
55. S.P. Janssens, A. Shimouchi, T. Quertermous, D.B. Bloch and K.D. Bloch: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/ nitric oxide synthase. Journal of Biological Chemistry 267: 14 519, 1992.
56. C.R. Lyons, G.J. Orloff and J.M. Cunningham: Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. Journal of Biological Chemistry 267: 6370, 1992.
57. Q.W. Xie, H.J. Cho, J. Calaycay, R.A. Mumford, K.M. Swiderek, T.D. Lee, A. Ding, T. Troso and C. Nathan: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225, 1992.
58. C.J. Lowenstein, C.S. Glatt, D.S. Bredt and S.H. Snyder: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proceedings of the National Academy of Sciences of the United States of America 89: 6711, 1992.
59. D.A. Geller, C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wang, D.K. Nakayama, R.L. Simmons, S.H. Snyder and T.R. Billiar: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 90: 3491, 1993.
60. S. Moncada, R.M. Palmer and E.A. Higgs: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43: 109, 1991.
61. R.A. Pufahl, P.G. Nanjappan, R.W. Woodard and M.A. Marletta: Mechanistic probes of N-hydroxylation of L-arginine by the inducible nitric oxide synthase from murine macrophages. Biochemistry 31: 6822, 1992.
62. P.L. Feldman, O.W. Griffith, H. Hong and D.J. Stuehr: Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation. Journal of Medicinal Chemistry 36: 491, 1993.
63. M.A. Dwyer, D.S. Bredt and S.H. Snyder: Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochemical and Biophysical Research Communications 176: 1136, 1991.
64. P. Klatt, K. Schmidt, G. Uray and B. Mayer: Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. Journal of Biological Chemistry 268: 14781, 1993.
65. Z.G. Zhang, D. Reif, J. Macdonald, W.X. Tang, D.K. Kamp, R.J. Gentile, W.C. Shakespeare, R.J. Murray and M. Chopp: ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. Journal of Cerebral Blood flow and Metabolism 16: 599, 1996.
66. D.J. Stuehr, N.S. Kwon, C.F. Nathan, O.W. Griffith, P.L. Feldman and J. Wiseman: N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. Journal of Biological Chemistry 266: 6259, 1991.
67. K.A. White and M.A. Marletta: Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31: 6627, 1992.
68. O.W. Griffith and D.J. Stuehr: Nitric oxide synthases: properties and catalytic mechanism. Annual Review of Physiology 57: 707, 1995.
69. B.R. Crane, A.S. Arvai, D.K. Ghosh, C. Wu, E.D. Getzoff, D.J. Stuehr and J.A. Tainer: Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279: 2121, 1998.
70. S. Pou, W.S. Pou, D.S. Bredt, S.H. Snyder and G.M. Rosen: Generation of superoxide by purified brain nitric oxide synthase. Journal of Biological Chemistry 267: 24 173, 1992.
71. T. Vorherr, L. Knöpfel, F. Hofmann, S. Mollner, T. Pfeuffer and E. Carafoli: The calmodulin binding domain of nitric oxide synthase and adenylylcyclase. Biochemistry 32: 6081, 1993.
72. G. Burnstock: Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system. Journal of Physiology 313: 1, 1981.
73. J.S. Gillespie, X.R. Liu and W. Martin: The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. British Journal of Pharmacology 98: 1080, 1989.
74. C.G. Li and M.J. Rand: Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clinical and Experimental Pharmacology Physiology 16: 933, 1989.
75. D.S. Bredt, P.M. Hwang and S.H. Snyder: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768, 1990.
76. P.L. Huang, T.M. Dawson, D.S. Bredt, S.H. Snyder and M.C. Fishman: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273, 1993.
77. E. Chung, D. Curtis, G. Chen, P.A. Marsden, R. Twells, W. Xu and M. Gardiner: Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis. American Journal of Human Genetics 58 363, 1996.
78. C. Iadecola, F. Zhang and X. Xu: Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. American Journal of Physiology 264: R738, 1993.
79. K. Nozaki, M.A. Moskowitz, K.I. Maynard, N. Koketsu, T.M. Dawson, D.S. Bredt and S.H. Snyder: Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. Journal of Cerebral Blood Flow and Metabolism 13: 70, 1993.
80. K.M. Welch: Drug therapy of migraine. New England Journal of Medicine 329: 1476, 1993.
81. H.K. Iversen and J. Olesen: Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16: 412, 1996.
82. K. Irikura, P.L. Huang, J. Ma, W.S. Lee, T. Dalkara, M.C. Fishman, T.M. Dawson, S.H. Snyder and M.A. Moskowitz: Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proceedings of the National Academy of Sciences of the United States of America 92: 6823, 1995.
83. A.L. Burnett, S.L. Tillman, T.S. Chang, J.I. Epstein, C.J. Lowenstein, D.S. Bredt, S.H. Snyder and P.C. Walsh: Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. Journal of Urology 150: 73, 1993.
84. A.L. Burnett, C.J. Lowenstein, D.S. Bredt, T.S. Chang and S.H. Snyder: Nitric oxide: a physiologic mediator of penile erection. Science 257: 401, 1992.
85. J. Rajfer, W.J. Aronson, P.A. Bush, F.J. Dorey and L.J. Ignarro: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New England Journal of Medicine 326: 90, 1992.
86. A.L. Burnett, R.J. Nelson, D.C. Calvin, J.X. Liu, G.E. Demas, S.L. Klein, L.J. Kriegsfeld, V.L. Dawson, T.M. Dawson and S.H. Snyder: Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Molecular Medicine 2: 288, 1996.
87. D. Vernet, L. Cai, H. Garban, M.L. Babbitt, F.T. Murray, J. Rajfer and N.F. Gonzalez-Cadavid: Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136: 5709, 1995.
88. S. Carrier, P. Nagaraju, D.M. Morgan, K. Baba, L. Nunes and T.F. Lue: Age decreases nitric oxide synthase-containing nerve fibers in the rat penis, Journal of Urology 157: 1088, 1997.
89. D.F. Penson, C. Ng, L. Cai, J. Rajfer and N.F. Gonzalez-Cadavid: Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biology of Reproduction 55: 567, 1996.
90. M. Boolel, M.J. Allen, S.A. Ballard, S. Gepi-Attee, G.J. Muirhead, A.M. Naylor, I.H. Osterloh and C. Gingell: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. International Journal of Impotence Research 8: 47, 1996.
91. S.A. Ballard, C.J. Gingell, K. Tang, L.A. Turner, M.E. Price and A.M. Naylor: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. Journal of Urology 159: 2164, 1998.
92. I. Goldstein, T.F. Lue, H. Padma-Nathan, R.C. Rosen, W.D. Steers and P.A. Wicker: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New England Journal of Medicine 338: 1397, 1998.
93. A.T. Chuang, J.D. Strauss, R.A. Murphy and W.D. Steers: Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. Journal of Urology 160: 257, 1998.
94. E.M. Schuman and D.V. Madison: Nitric oxide and synaptic function. Annual Reviews of Neuroscience 17: 153, 1994.
95. K. Shibuki and D. Okada: Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349: 326, 1991.
96. H. Son, R.D. Hawkins, K. Martin, M. Kiebler, P.L. Huang, M.C. Fishman and E.R. Kandel: Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015, 1996.
97. D.B. Hirsch, J.P. Steiner, T.M. Dawson, A. Mammen, E. Hayek and S.H. Snyder: Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Current Biology 3: 749, 1993.
98. G. Lonart, J. Wang and K.M. Johnson: Nitric oxide induces neurotransmitter release from hippocampal slices. European Journal of Pharmacology 220: 271, 1992.
99. B.G. Dickie, M.J. Lewis and J.A. Davies: NMDA-induced release of nitric oxide potentiates aspartate overflow from cerebellar slices. Neuroscience Letters 138: 145, 1992.
100. P.R. Montague, C.D. Gancayco, M.J. Winn, R.B. Marchase and M.J. Friedlander: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263: 973, 1994.
101. I. Hanbauer, D. Wink, Y. Osawa, G.M. Edelman and J.A. Gally: Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport 3: 409, 1992.
102. S.M. McCann and V. Rettori: The role of nitric oxide in reproduction. Proceedings of the Society for Experimental Biology and Medicine 211: 7, 1996.
103. V. Rettori, N. Belova, W.L. Dees, C.L. Nyberg, M. Gimeno and S.M. McCann: Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proceedings of the National Academy of Sciences of the United States of America 90: 10 130, 1993.
104. S.K. Mani, J.M. Allen, V. Rettori, S.M. McCann, B.W. O'Malley and J.H. Clark: Nitric oxide mediates sexual behavior in female rats. Proceedings of the National Academy of Sciences of the United States of America 91: 6468, 1994.
105. V. Rettori, G. Canteros, R. Renoso, M. Gimeno and S.M. McCann: Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 94: 2741, 1997.
106. H.H. Wu, C.V. Williams and S.C. McLoon: Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 265: 1593, 1994.
107. R.D. Hawkins: NO honey, I don't remember. Neuron 16: 465, 1996.
108. K.M. Kendrick, R. Guevara-Guzman, J. Zorrilla, M.R. Hinton, K.D. Broad, M. Mimmack and S. Ohkura: Formation of olfactory memories mediated by nitric oxide. Nature 388: 670, 1997.
109. S.T. Meller and G.F. Gebhart: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127, 1993.
110. G. Crosby, J.J. Marota and P.L. Huang: Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 69: 1013, 1995.
111. F. Silvagno, H. Xia and D.S. Bredt: Neuronal nitric oxide synthase-m, an alternatively spliced isoform expressed in differentiated skeletal muscle. Journal of Biological Chemistry 271: 11 204, 1996.
112. L. Kobzik, M.B. Reid, D.S. Bredt and J.S. Stamler: Nitric oxide in skeletal muscle. Nature 372: 546, 1994.
113. J. Boczkowski, S. Lanone, D. Ungureanu-Longrois, G. Danialou, T. Fournier and M. Aubier: Induction of diaphragmatic nitric oxide synthase after endotoxin, administration in rats: role on diaphragmatic contractile dysfunction. Journal of Chemical Investigation 98: 1550, 1996.
114. R.M. McAllister, T. Hirai and T.I. Musch: Contribution of endothelium-derived nitric oxide (EDNO) to the skeletal muscle blood flow response to exercise. Medicine and Science in Sports and Exercise 27: 1145, 1995.
115. A. Corcondilas, G.T. Koroxenidis and J.T. Shepherd: Effect of a brief contraction of forearm muscles on forearm blood flow. Journal af Applied Physiology 19: 142, 1964.
116. S.N. Hussain, D.J. Stewart, J.P. Ludemann and S. Magder: Role of endothelium-derived relaxing factor in active hyperemia of the canine diaphragm. Journal of Applied Physiology 72: 2393, 1992.
117. T. Hirai, M.D. Visneski, K.J. Kearns, R. Zelis and T.I. Musch: Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. Journal of Applied Physiology 77: 1288, 1994.
118. C.K. Dyke, D.N. Proctor, N.M. Dietz and M.J. Joyner: Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. Journal of Physiology 488: 259, 1995.
119. K.M. Anderson and J.E. Faber: Differential sensitivity of arteriolar alpha 1-and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circulation Research 69: 174, 1991.
120. G.D. Thomas, J. Hansen and R.G. Victor: Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. American Journal of Physiology 266: H920, 1994.
121. G.D. Thomas and R.G. Victor: Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. Journal of Physiology 506: 817, 1998.
122. G.D. Thomas, M. Sander, K.S. Lau, P.L. Huang, J.T. Stull and R.G. Victor: Proceedings of the National Academy of Sciences, 1999 (in press).
123. J.E. Brenman, D.S. Chao, H. Xia, K. Aldape and D.S. Bredt: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743, 1995.
124. J.E. Brenman, D.S. Chao, S.H. Gee, A.W. McGee, S.E. Craven, D.R. Santillano, F. Huang, H. Xia, M.F. Peters, S.C. Froehner and D.S. Bredt: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell 84: 757, 1996.
125. W.J. Chang, S.T. Iannaccone, K.S. Lau, B.S. Masters, T.J. McCabe, K. McMillan, R.C. Padre, M.J. Spencer, J.G. Tidball and J.T. Stull: Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 93: 9142, 1996.
126. C. Webster, L. Silberstein, A.P. Hays and H.M. Blau: Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503, 1988.
127. K.S. Lau, R.W. Grange, W.J. Chang, K.E. Kamm, I. Sarelius and J.T. Stull: Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Letters 431: 71, 1998.
128. T.W. Balon and J.L. Nadler: Evidence that nitric oxide increases glucose transport in skeletal muscle. Journal of Applied Physiology 82: 359, 1997.
129. J.G. Tidball, B. Lavergne, K.S. Lau, M.J. Spencer, J.T. Stull and M. Wehling: Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. American Journal of Physiology 275: C260, 1998.
130. D.S. Chao, F. Silvagno and D.S. Bredt: Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. Journal of Neurochemistry 71: 784, 1998.
131. R.H. Crosbie, V. Straub, H.Y. Yun, J.C. Lee, J.A. Rafael, J.S. Chamberlain, V.L. Dawson, T.M. Dawson and K.P. Campbell: mdx muscle pathology is independent of nNOS perturbation. Human Molecular Genetics 7: 823, 1998.
132. D.S. Chao, R.M. Gorospe, J.E. Brenman, J.A. Rafael, M.F. Peters, S.C. Froehner, E.P. Hoffman, J.S. Chamberlain and D.S. Bredt: Selective loss of sarcolemmal nitric oxide synthase in Becker Muscular Dystrophy. Journal of Experimental Medicine 184: 609, 1996.
133. E.E. Daniel, C. Haugh, Z. Woskowska, S. Cipris, J. Jury and J.E. Fox-Threlkeld: Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. American Journal of Physiology 266: G31, 1994.
134. H. Mashimo, X.D. He, P.L. Huang, M.C. Fishman and R.K. Goyal: Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. Journal of Clinical Investigation 98: 8, 1996.
135. H.-C. Kornau, P.H. Seeburg and M.B. Kennedy: Interaction of ion channels and receptors with PDZ domains. Current Opinions in Neurobiology 7: 368, 1997.
136. M. Sheng: PDZs and receptor/channel clustering: rounding up the latest suspects [comment]. Neuron 17: 575, 1996.
137. S.R. Jaffrey and S.H. Snyder: PIN: An associated protein inhibitor of neuronal nitric oxide synthase. Science 274: 774, 1996.
138. D.W. Choi: Glutamate receptors and the induction of excitotoxic neuronal death. Progress in Brain Research 100: 47, 1994.
139. R.P. Simon, J.H. Swan, T. Griffiths and B.S. Meldrum: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850, 1984.
140. V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt and S.H. Snyder: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 88: 6368, 1991.
141. V.L. Dawson, V.M. Kizushi, P.L. Huang, S.H. Snyder and T.M. Dawson: Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. Journal of Neuroscience 16: 2479, 1996.
142. V.L. Dawson and T.M. Dawson: Nitric oxide in neuronal degeneration. Proceeding of the Society for Experimental Biology and Medicine 211: 33, 1996.
143. Z. Huang, P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman and M.A. Moskowitz: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883, 1994.
144. Z. Huang, P.L. Huang, J. Ma, W. Meng, C. Ayata, M.C. Fishman and M.A. Moskowitz: Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. Journal of Cerebral Blood Flow and Metabolism 16: 981, 1996.
145. C. Iadecola: Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neuroscience 20: 132, 1997.
146. J.S. Stamler: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931, 1994.
147. J.C. Drapier and J.B. Hibbs, Jr.: Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Methods in Enzymology 269: 26, 1996.
148. G.C. Brown: Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Letters 369: 136, 1995.
149. J.S. Beckman and W.H. Koppenol: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. A American Journal of Physiology 271: C1424, 1996.
150. H. Kinouchi, C.J. Epstein, T. Mizui, E. Carlson, S.F. Chen and P.H. Chan: Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 88: 11 158, 1991.
151. A.F. Samdani, T.M. Dawson and V.L. Dawson: Nitric oxide synthase in models of focal ischemia. Stroke 28: 1283, 1997.
152. R.J. Ferrante, N.W. Kowall, M.F. Beal, E.P. Richardson, E.D. Bird and J.B. Martin: Selective sparing of a class of striatal neurons in Huntington's disease. Science 230: 561, 1985.
153. J.Y. Koh, S. Peters and D.W. Choi: Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 234: 73, 1986.
154. S. Inagaki, K. Suzuki, N. Taniguchi and H. Takagi: Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum. Brain Research 549: 174, 1991.
155. W.R. Galpern, R.T. Matthews, M.F. Beal and O. Isacson: NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Neuroreport 7: 2639, 1996.
156. P. Hantraye, E. Brouillet, R. Ferrante, S. Palfi, R. Dolan, R.T. Matthews and M.F. Beal: Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine 2: 1017, 1996.
157. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson and T.M. Dawson: Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 93: 4565, 1996.
158. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, L.I. Athanassiadou Golbe and R.L. Nussbaum: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045, 1997.
159. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini and G.P. Bates: Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537, 1997.
160. K.S. Christopherson and D.S. Bredt: Nitric oxide in excitable tissues: physiological roles and disease. Journal of Clinical Investigation 100: 2424, 1997.